- 0 Comments
- News
This trial plans to enroll 726 patients across approximately 246 centers in 26 countries, 13 of which are in Europe and 6 in Portugal. Gastric cancer is the 5th most prevalent cancer worldwide. The aim of this trial is to evaluate the efficacy and safety of an intravenously administered drug in patients with HER2-positive gastric […]